Course “Verification vs. Validation - Product Process Software and QMS " has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion.
Overview:
This course will review the company Master Validation Plan for major key inputs and CGMP deficiencies. It will address the FDA's newer & tougher regulatory stance. This course's aim is to prove "Product Risk Based V&V" by sufficient, targeted and documented risk-based V&V test case elements/scripts. It will teach participants to evaluate its elements against ISO 14971 and ICH Q9 for hazard analysis and product risk management.
This course will evaluate different field-tested, U.S. FDA-reviewed V&V protocols; how to employ equipment/process Requirements Specs / DQs, IQs, OQs, & PQs, or their equivalents per ASTM E2500, all against a background of limited company resources.
It will review a matrix that simplifies "as-product", in-product", process and equipment, et al, sof...
Read more
Course “Verification vs. Validation - Product Process Software and QMS " has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion.
Overview:
This course will review the company Master Validation Plan for major key inputs and CGMP deficiencies. It will address the FDA's newer & tougher regulatory stance. This course's aim is to prove "Product Risk Based V&V" by sufficient, targeted and documented risk-based V&V test case elements/scripts. It will teach participants to evaluate its elements against ISO 14971 and ICH Q9 for hazard analysis and product risk management.
This course will evaluate different field-tested, U.S. FDA-reviewed V&V protocols; how to employ equipment/process Requirements Specs / DQs, IQs, OQs, & PQs, or their equivalents per ASTM E2500, all against a background of limited company resources.
It will review a matrix that simplifies "as-product", in-product", process and equipment, et al, software VT&V, to assure key FDA requirements are not overlooked. While considering the QMS and 21 CFR Part 11; this course will make practical application of these same in two hands-on sessions.
Why you should attend?
This session helps participants:
Understand Verification and Validation, differences and how they work together;
Discuss recent regulatory expectations;
Know how to document a "risk-based" rationale, and use it in a resource-constrained environment;
Determine key "milestones" and "tasks" in a project;
Locate and document key subject "inputs";
Compile "generic" Master and Individual Validation Plans;
Learn the key element of a Product V&V File/Protocol;
Understand how to develop Process and/or Production/Test Equipment V&V Files/Protocols;
Get a grasp of basic Test Case construction;
Understand sample sizes and their justification;
Learn the key elements of Software V&V expected by the FDA and how to document;
Deal with hardware and software vendors, sales and marketing
Consider a field-tested software V&V documentation "model";
See how to compile QMS Electronic Records and Electronic Signatures V&Vs to satisfy 21 CFR Part 11.
Who Will Benefit:
This workshop will provide valuable assistance to all regulated companies that need to review and modify their Master Validation Planning and V&V activities / plan(s). This information addresses Medical Devices, Pharmaceutical, Diagnostic, and Biologics requirements and implementation. The employees
Who will benefit include?
Senior and middle management and staff
Regulatory Affairs
Quality Assurance or Quality Control Professionals
QA/QC
IT/IS
R&D
Production Management
Manufacturing Engineers
Process Engineers
Software Engineers
Project Managers
Hardware and software vendors, sales and marketing
Any professional tasked with V&V responsibilities
Agenda:
Day 1 Schedule:
Lecture 1:
Master Validation Planning and the Master Validation Plan(s)
Lecture 2:
Product, Process / Equipment Hardware V&V
Lecture 3:
Product / Device V&V
Lecture 4:
Software V&V
Lecture 5:
Quality Management System / 21 CFR Part 11 V&V
Lecture 6:
Summary of morning discussion
Lecture 7:
Group activity on the MVPs
Lecture 8:
Review of group activity and Q&A
Day 2 Schedule:
Lecture 1:
Software V&V documentation "model"
Lecture 2:
Software V&V protocols - "black box", "white box"
Lecture 3:
Electronic Records and Electronic Signatures (Part 11)
Lecture 4:
Summary of morning discussion
Lecture 5:
Group activity on 1) hardware / equipment, and 2) software V&V protocols
Lecture 6:
Review of group activity and Q&A
Lecture 7:
Course summary discussion
Lecture 8:
Summary of morning discussion
Lecture 9:
Group activity on the MVPs
Lecture 10:
Review of group activity and Q&A
Speaker
John E Lincoln is Principal of J. E. Lincoln and Associates LLC, a consulting company. John, a graduate of UCLA, is a medical device and Regulatory Affairs consultant. He has helped companies to implement or modify their GMP systems and procedures, product risk management and U.S. FDA responses. In addition, he has successfully designed, written and run all types of process, equipment and software qualifications/validations, which have passed FDA audit or submission scrutiny, and have been described in peer-reviewed technical articles and workshops worldwide.
Venue: Hilton Grand Vacations Suites at the Flamingo
Hotel: Hilton Grand Vacations Suites at the Flamingo 3575 Las Vegas Boulevard South, Las Vegas, Nevada, 89109-4313, USA
Date: October 15th & 16th, 2015
Time: 9:00 AM to 6:00 PM
Price: $1,695.00 (Seminar for One Delegate)
Register now and save $200. (Early Bird) Until August 31, Early Bird Price: $1,695.00 From September 01 to October 13, Regular Price: $1,895.00
Contact Information:
NetZealous LLC,
DBA GlobalCompliancePanel
161 Mission Falls Lane,
Suite 216, Fremont, CA 94539, USA
USA Phone: 800-447-9407
Fax: 302-288-6884
support@globalcompliancepanel.com
http://www.globalcompliancepanel.com
Event Registration Link: https://goo.gl/Rxmg70
